Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA GLENMARK PHARMA AUROBINDO PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 23.0 -31.4 - View Chart
P/BV x 2.4 2.9 83.2% View Chart
Dividend Yield % 0.3 0.3 105.5%  

Financials

 AUROBINDO PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
GLENMARK PHARMA
Mar-23
AUROBINDO PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs715487 146.7%   
Low Rs397349 113.9%   
Sales per share (Unadj.) Rs424.2460.4 92.1%  
Earnings per share (Unadj.) Rs32.913.4 246.0%  
Cash flow per share (Unadj.) Rs54.135.0 154.5%  
Dividends per share (Unadj.) Rs3.002.50 120.0%  
Avg Dividend yield %0.50.6 90.2%  
Book value per share (Unadj.) Rs458.1335.1 136.7%  
Shares outstanding (eoy) m585.94282.17 207.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.9 144.3%   
Avg P/E ratio x16.931.3 54.1%  
P/CF ratio (eoy) x10.311.9 86.1%  
Price / Book Value ratio x1.21.2 97.3%  
Dividend payout %9.118.7 48.8%   
Avg Mkt Cap Rs m325,753117,953 276.2%   
No. of employees `000NANA-   
Total wages/salary Rs m35,22327,810 126.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,554129,901 191.3%  
Other income Rs m2,9063,168 91.7%   
Total revenues Rs m251,460133,069 189.0%   
Gross profit Rs m37,07015,125 245.1%  
Depreciation Rs m12,4466,113 203.6%   
Interest Rs m1,4053,496 40.2%   
Profit before tax Rs m26,1258,685 300.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8494,911 139.5%   
Profit after tax Rs m19,2773,774 510.8%  
Gross profit margin %14.911.6 128.1%  
Effective tax rate %26.256.5 46.4%   
Net profit margin %7.82.9 266.9%  
BALANCE SHEET DATA
Current assets Rs m214,59998,737 217.3%   
Current liabilities Rs m114,93850,455 227.8%   
Net working cap to sales %40.137.2 107.9%  
Current ratio x1.92.0 95.4%  
Inventory Days Days217 307.8%  
Debtors Days Days66115 57.0%  
Net fixed assets Rs m176,66876,920 229.7%   
Share capital Rs m586282 207.6%   
"Free" reserves Rs m267,81394,281 284.1%   
Net worth Rs m268,39994,563 283.8%   
Long term debt Rs m6,19038,521 16.1%   
Total assets Rs m392,125175,658 223.2%  
Interest coverage x19.63.5 562.4%   
Debt to equity ratio x00.4 5.7%  
Sales to assets ratio x0.60.7 85.7%   
Return on assets %5.34.1 127.4%  
Return on equity %7.24.0 180.0%  
Return on capital %10.09.2 109.5%  
Exports to sales %33.70-   
Imports to sales %15.30-   
Exports (fob) Rs m83,703NA-   
Imports (cif) Rs m38,060NA-   
Fx inflow Rs m85,48346,464 184.0%   
Fx outflow Rs m41,44712,712 326.0%   
Net fx Rs m44,03633,751 130.5%   
CASH FLOW
From Operations Rs m23,8686,254 381.6%  
From Investments Rs m-39,778-5,285 752.7%  
From Financial Activity Rs m18,144-775 -2,342.5%  
Net Cashflow Rs m2,298325 707.0%  

Share Holding

Indian Promoters % 48.8 46.7 104.5%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.3 34.7 119.2%  
FIIs % 20.7 23.7 87.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 53.4 90.3%  
Shareholders   241,944 209,931 115.2%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Glenmark Pharma Share Price Performance

Period Aurobindo Pharma Glenmark Pharma S&P BSE HEALTHCARE
1-Day 1.82% -0.57% 1.18%
1-Month 5.96% 5.16% -0.75%
1-Year 113.07% 112.94% 61.82%
3-Year CAGR 7.78% 27.51% 18.16%
5-Year CAGR 7.18% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.